Prevalence of anemia in patients with type 1 and type 2 diabetes mellitus with chronic renal disease

S. Martynov, Мартынов Сергей Андреевич, M. Shestakova, Шестакова Марина Владимировна, E. Shilov, Шилов Евгений Михайлович, M. Shamkhalova, Шамхалова Минара Шамхаловна, O. Vikulova, Викулова Ольга Константиновна, O. Y. Sukhareva, Сухарева Ольга Юрьевна, N. P. Trubitsyna, Трубицина Наталья Петровна, D. Egorova, Егорова Дарья Никитична, O. Bondarenko, Бондаренко Ольга Николаевна, I. Dedov, Дедов Иван Иванович
{"title":"Prevalence of anemia in patients with type 1 and type 2 diabetes mellitus with chronic renal disease","authors":"S. Martynov, Мартынов Сергей Андреевич, M. Shestakova, Шестакова Марина Владимировна, E. Shilov, Шилов Евгений Михайлович, M. Shamkhalova, Шамхалова Минара Шамхаловна, O. Vikulova, Викулова Ольга Константиновна, O. Y. Sukhareva, Сухарева Ольга Юрьевна, N. P. Trubitsyna, Трубицина Наталья Петровна, D. Egorova, Егорова Дарья Никитична, O. Bondarenko, Бондаренко Ольга Николаевна, I. Dedov, Дедов Иван Иванович","doi":"10.14341/DM9369","DOIUrl":null,"url":null,"abstract":"Background . Diabetes mellitus (DM) is a non-infectious disease with a high prevalence worldwide and is one of the most common causes of diabetic kidney disease (DKD). Anaemia is a well-known complication of chronic kidney disease (CKD) and has been estimated to affect one in three adults with DM. Aims . To evaluate the prevalence and severity of anaemia among patients with DKD and to compare the distribution of anaemia among patients with diabetic and non-diabetic CKD. Methods . A total of 2,015 patients with DM [n = 807 with type 1 DM (T1DM); n = 1,208 with type 2 DM (T2DM)] and 244 patients with biopsy-proven chronic glomerulonephritis (CGN) were selected. Patients with glomerular filtration rate (GFR) of <15 ml/min/1,73 m2 (stage 5 CKD) and treated by erythropoietin-stimulating agents and/or iron medication were not included. The presence of anaemia was defined as haemoglobin (Hb) of <130 g/l in men and <120 g/l in woman. GFR was calculated using the MDRD formula. CKD stages were defined based on stages 1–4 of CKD by KDOQI and KDIGO guidelines: stage 1 (GFR ≥ 90 ml/min/1.73 m2); stage 2 (GFR 60–89 ml/min/1.73 m2); stage 3 (GFR 30–59 ml/min/1.73 m2); stage 3a (45–59 ml/min/1.73 m2); stage 3b (GFR 30–44 ml/min/1.73 m2); stage 4 (GFR 15–29 ml/min/1.73 m2). Results . Rates of anaemia were higher among patients with DM and DKD (38.8% and 22.6% for T1DM and T2DM, respectively) than diabetic patients without DKD (16.6% and 11.5%, respectively. Prevalence of anaemia by CKD stage increased from 23.3% in stage 1 to 80% in stage 4 among patients with T1DM, and from 16.9% to 81 % among patients with T2DM. The prevalence of anaemia was also higher among protoeinuric patients (53.9% and 34.4% for T1DM and T2DM, respectively) relative to microalbuminuric patients (29.4% and 17.6%, respectively). Anaemia prevalence was significantly greater in DKD due to T1DM (53.9%) than in CGN (19.7), and the rates did not differ based on stages of CKD. Conclusions . We found a two-fold higher rate of anaemia among patients with DM and CKD than patients with DM and non-DKD. In addition, we found that the frequency of anaemia depends on renal function (i.e., stage of CKD) and degree of albuminuria. Taken together, anaemia is highly prevalent among patients with T1DM and DKD compared with patients with chronic CGN, without differences in its severity.","PeriodicalId":73708,"journal":{"name":"Journal of diabetes mellitus","volume":"155 1","pages":"318-328"},"PeriodicalIF":0.0000,"publicationDate":"2017-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of diabetes mellitus","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14341/DM9369","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 6

Abstract

Background . Diabetes mellitus (DM) is a non-infectious disease with a high prevalence worldwide and is one of the most common causes of diabetic kidney disease (DKD). Anaemia is a well-known complication of chronic kidney disease (CKD) and has been estimated to affect one in three adults with DM. Aims . To evaluate the prevalence and severity of anaemia among patients with DKD and to compare the distribution of anaemia among patients with diabetic and non-diabetic CKD. Methods . A total of 2,015 patients with DM [n = 807 with type 1 DM (T1DM); n = 1,208 with type 2 DM (T2DM)] and 244 patients with biopsy-proven chronic glomerulonephritis (CGN) were selected. Patients with glomerular filtration rate (GFR) of <15 ml/min/1,73 m2 (stage 5 CKD) and treated by erythropoietin-stimulating agents and/or iron medication were not included. The presence of anaemia was defined as haemoglobin (Hb) of <130 g/l in men and <120 g/l in woman. GFR was calculated using the MDRD formula. CKD stages were defined based on stages 1–4 of CKD by KDOQI and KDIGO guidelines: stage 1 (GFR ≥ 90 ml/min/1.73 m2); stage 2 (GFR 60–89 ml/min/1.73 m2); stage 3 (GFR 30–59 ml/min/1.73 m2); stage 3a (45–59 ml/min/1.73 m2); stage 3b (GFR 30–44 ml/min/1.73 m2); stage 4 (GFR 15–29 ml/min/1.73 m2). Results . Rates of anaemia were higher among patients with DM and DKD (38.8% and 22.6% for T1DM and T2DM, respectively) than diabetic patients without DKD (16.6% and 11.5%, respectively. Prevalence of anaemia by CKD stage increased from 23.3% in stage 1 to 80% in stage 4 among patients with T1DM, and from 16.9% to 81 % among patients with T2DM. The prevalence of anaemia was also higher among protoeinuric patients (53.9% and 34.4% for T1DM and T2DM, respectively) relative to microalbuminuric patients (29.4% and 17.6%, respectively). Anaemia prevalence was significantly greater in DKD due to T1DM (53.9%) than in CGN (19.7), and the rates did not differ based on stages of CKD. Conclusions . We found a two-fold higher rate of anaemia among patients with DM and CKD than patients with DM and non-DKD. In addition, we found that the frequency of anaemia depends on renal function (i.e., stage of CKD) and degree of albuminuria. Taken together, anaemia is highly prevalent among patients with T1DM and DKD compared with patients with chronic CGN, without differences in its severity.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
1型和2型糖尿病合并慢性肾脏疾病患者贫血的患病率
背景。糖尿病(DM)是一种世界性的高发非传染性疾病,是糖尿病肾病(DKD)最常见的病因之一。贫血是慢性肾脏疾病(CKD)的一种众所周知的并发症,据估计,三分之一的成年糖尿病患者患有贫血。评估DKD患者贫血的患病率和严重程度,并比较糖尿病和非糖尿病性CKD患者贫血的分布。方法。共有2015例1型糖尿病(T1DM)患者[n = 807];n = 1208例2型糖尿病(T2DM)患者和244例活检证实的慢性肾小球肾炎(CGN)患者。肾小球滤过率(GFR) <15 ml/min/1,73 m2(5期CKD)并接受促红细胞生成素和/或铁药物治疗的患者未纳入研究。贫血的定义为男性血红蛋白(Hb) <130 g/l,女性<120 g/l。GFR采用MDRD公式计算。KDOQI和KDIGO指南根据CKD的1 - 4期定义CKD分期:1期(GFR≥90 ml/min/1.73 m2);第二阶段(GFR 60-89 ml/min/1.73 m2);3期(GFR 30-59 ml/min/1.73 m2);3a期(45-59 ml/min/1.73 m2);3b期(GFR 30-44 ml/min/1.73 m2);第四阶段(GFR 15-29 ml/min/1.73 m2)。结果。糖尿病合并DKD患者的贫血率(T1DM和T2DM分别为38.8%和22.6%)高于无DKD患者(分别为16.6%和11.5%)。在T1DM患者中,CKD阶段贫血的患病率从1期的23.3%增加到4期的80%,在T2DM患者中从16.9%增加到81%。蛋白尿原患者的贫血患病率(T1DM和T2DM分别为53.9%和34.4%)也高于微量蛋白尿患者(分别为29.4%和17.6%)。由T1DM引起的DKD的贫血患病率(53.9%)明显高于CGN(19.7%),且不同CKD分期的发生率无差异。结论。我们发现糖尿病和CKD患者的贫血率比糖尿病和非dkd患者高两倍。此外,我们发现贫血的频率取决于肾功能(即CKD的分期)和蛋白尿的程度。综上所述,与慢性CGN患者相比,贫血在T1DM和DKD患者中非常普遍,其严重程度无差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Dyslipidemia in Adults with Type 2 Diabetes in a Rural Community in Ganadougou, Mali: A Cross-Sectional Study. Nobel prize winners in metabolism history and diabetology Early intensification of therapy for type 2 diabetes mellitus and achievement of the target level of glycohemoglobin HbA1c are necessary factors to reduce the risk of micro- and macrovascular complications Detectıon of vısual-audıtory reactıon rates ın ındıvıduals wıth type 2 dıabetes mellıtus Type 2 diabetes clusters in the Novosibirsk region
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1